Clinical trials
Phase 1 Carcinoma, Hepatocellular trials in Italy
Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.
17 trials match Source: ClinicalTrials.gov registrations
Trials started per year
By phase, 2000 to 2026.
| Category | Trials |
|---|---|
| 2009 | 2 |
| 2011 | 1 |
| 2015 | 1 |
| 2016 | 2 |
| 2017 | 3 |
| 2019 | 2 |
| 2020 | 1 |
| 2021 | 2 |
| 2022 | 2 |
| 2024 | 1 |
Status
Trials by registry status. Select a bar to filter.
| Category | Trials |
|---|---|
| Completed | 10 |
| Active, not recruiting | 3 |
| Recruiting | 3 |
| Terminated | 1 |
Top lead sponsors
A sponsor with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| ArQule, Inc., a subsidiary of Merck Sharp & Dohme LLC, a subsidiary of Merck & Co., Inc. (Rahway, NJ USA) | 2 |
| Exelixis | 2 |
| AbbVie | 1 |
| Alnylam Pharmaceuticals | 1 |
| Azienda Ospedaliera Universitaria Mater Domini, Catanzaro | 1 |
| Blueprint Medicines Corporation | 1 |
| Celgene | 1 |
| Eisai Co., Ltd. | 1 |
| Eli Lilly and Company | 1 |
| H3 Biomedicine Inc. | 1 |
Top conditions
MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.
| Category | Trials |
|---|---|
| Carcinoma, Hepatocellular | 17 |
| Carcinoma, Non-Small-Cell Lung | 7 |
| Colorectal Neoplasms | 5 |
| Neoplasms | 5 |
| Carcinoma, Renal Cell | 4 |
| Liver Neoplasms | 4 |
| Squamous Cell Carcinoma of Head and Neck | 4 |
| Stomach Neoplasms | 4 |
| Triple Negative Breast Neoplasms | 4 |
| Carcinoma, Transitional Cell | 3 |
Trials
Showing 1 to 17 of 17. Each trial links to its page on Pharma Observatory.
Recently changed trials
Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.
No changes to these trials in the last 7 days.
Go deeper on Pharma Observatory
Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.